OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recent Advances and Challenges in Cancer Immunotherapy
Chelsea Peterson, Nathan Denlinger, Yiping Yang
Cancers (2022) Vol. 14, Iss. 16, pp. 3972-3972
Open Access | Times Cited: 75
Chelsea Peterson, Nathan Denlinger, Yiping Yang
Cancers (2022) Vol. 14, Iss. 16, pp. 3972-3972
Open Access | Times Cited: 75
Showing 1-25 of 75 citing articles:
Nanomaterials in tumor immunotherapy: new strategies and challenges
Xudong Zhu, Shenglong Li
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 110
Xudong Zhu, Shenglong Li
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 110
Titanium‐Based Nanoarchitectures for Sonodynamic Therapy‐Involved Multimodal Treatments
Aziz Maleki, Mohammad Seyedhamzeh, Meng Yuan, et al.
Small (2023) Vol. 19, Iss. 12
Closed Access | Times Cited: 45
Aziz Maleki, Mohammad Seyedhamzeh, Meng Yuan, et al.
Small (2023) Vol. 19, Iss. 12
Closed Access | Times Cited: 45
mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond
Mariona Estapé Sentí, Lucía García del Valle, Raymond M. Schiffelers
Advanced Drug Delivery Reviews (2024) Vol. 206, pp. 115190-115190
Open Access | Times Cited: 22
Mariona Estapé Sentí, Lucía García del Valle, Raymond M. Schiffelers
Advanced Drug Delivery Reviews (2024) Vol. 206, pp. 115190-115190
Open Access | Times Cited: 22
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 19
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 19
Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies
Shan Muhammad, Tao Fan, Yang Hai, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 41
Shan Muhammad, Tao Fan, Yang Hai, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 41
Nanomaterials: Breaking through the bottleneck of tumor immunotherapy
Yue Kang, Shenglong Li
International Journal of Biological Macromolecules (2023) Vol. 230, pp. 123159-123159
Closed Access | Times Cited: 38
Yue Kang, Shenglong Li
International Journal of Biological Macromolecules (2023) Vol. 230, pp. 123159-123159
Closed Access | Times Cited: 38
Manganese-Enriched Zinc Peroxide Functional Nanoparticles for Potentiating Cancer Immunotherapy
Mengli Zhou, Shuang Liang, Dan Liu, et al.
Nano Letters (2023) Vol. 23, Iss. 22, pp. 10350-10359
Closed Access | Times Cited: 33
Mengli Zhou, Shuang Liang, Dan Liu, et al.
Nano Letters (2023) Vol. 23, Iss. 22, pp. 10350-10359
Closed Access | Times Cited: 33
Artificial intelligence in cancer immunotherapy: Applications in neoantigen recognition, antibody design and immunotherapy response prediction
Li Tong, Yupeng Li, Xiaoyi Zhu, et al.
Seminars in Cancer Biology (2023) Vol. 91, pp. 50-69
Closed Access | Times Cited: 26
Li Tong, Yupeng Li, Xiaoyi Zhu, et al.
Seminars in Cancer Biology (2023) Vol. 91, pp. 50-69
Closed Access | Times Cited: 26
Opportunities and challenges of CD47-targeted therapy in cancer immunotherapy
Q. Chen, XUEJUN GUO, Wenxue Ma
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 32, Iss. 1, pp. 49-60
Open Access | Times Cited: 25
Q. Chen, XUEJUN GUO, Wenxue Ma
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 32, Iss. 1, pp. 49-60
Open Access | Times Cited: 25
Current strategies for targeting HPK1 in cancer and the barriers to preclinical progress
Hui Chen, Xiangna Guan, Chi He, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 4, pp. 237-250
Closed Access | Times Cited: 8
Hui Chen, Xiangna Guan, Chi He, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 4, pp. 237-250
Closed Access | Times Cited: 8
A new era in cancer treatment: harnessing ZIF-8 nanoparticles for PD-1 inhibitor delivery
Farangis Rastin, Mahsa Akbari Oryani, Sonia Iranpour, et al.
Journal of Materials Chemistry B (2023) Vol. 12, Iss. 4, pp. 872-894
Closed Access | Times Cited: 18
Farangis Rastin, Mahsa Akbari Oryani, Sonia Iranpour, et al.
Journal of Materials Chemistry B (2023) Vol. 12, Iss. 4, pp. 872-894
Closed Access | Times Cited: 18
Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)
Yuriko Mori, Emil Novruzov, Dominik Schmitt, et al.
npj Imaging (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 8
Yuriko Mori, Emil Novruzov, Dominik Schmitt, et al.
npj Imaging (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 8
Spatiotemporal Controllable Sono‐Nanovaccines Driven by Free‐Field Based Whole‐Body Ultrasound for Personalized Cancer Therapy
Yang Wang, Guangzhe Li, Jianlong Su, et al.
Advanced Science (2024) Vol. 11, Iss. 14
Open Access | Times Cited: 6
Yang Wang, Guangzhe Li, Jianlong Su, et al.
Advanced Science (2024) Vol. 11, Iss. 14
Open Access | Times Cited: 6
Enhanced cellular therapy: revolutionizing adoptive cellular therapy
Mengyao Xu, Na Zeng, Chen‐Qian Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Mengyao Xu, Na Zeng, Chen‐Qian Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Empagliflozin Alleviates Carfilzomib-Induced Cardiotoxicity in Mice by Modulating Oxidative Stress, Inflammatory Response, Endoplasmic Reticulum Stress, and Autophagy
Mina Y. George, Mohamed S. Dabour, Eman Rashad, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 671-671
Open Access | Times Cited: 6
Mina Y. George, Mohamed S. Dabour, Eman Rashad, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 671-671
Open Access | Times Cited: 6
Polarization of M2 Tumor-associated Macrophages (TAMs) in Cancer Immunotherapy
Indy Bui, Benjamin Bonavida
Critical Reviews™ in Oncogenesis (2024) Vol. 29, Iss. 4, pp. 75-95
Closed Access | Times Cited: 5
Indy Bui, Benjamin Bonavida
Critical Reviews™ in Oncogenesis (2024) Vol. 29, Iss. 4, pp. 75-95
Closed Access | Times Cited: 5
Biomimetic Cell-Derived Nanoparticles: Emerging Platforms for Cancer Immunotherapy
Tingting Hu, Yuezhou Huang, Jing Liu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1821-1821
Open Access | Times Cited: 11
Tingting Hu, Yuezhou Huang, Jing Liu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1821-1821
Open Access | Times Cited: 11
Metal-Based Nanoparticles for Cancer Metalloimmunotherapy
I. Suliman, K. H. Kim, Weihsuan Chen, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 2003-2003
Open Access | Times Cited: 11
I. Suliman, K. H. Kim, Weihsuan Chen, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 2003-2003
Open Access | Times Cited: 11
Prophylactic and therapeutic vaccine development: advancements and challenges
Induni Nayodhara Weerarathna, Elijah Skarlus Doelakeh, Lydia Kiwanuka, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 4
Induni Nayodhara Weerarathna, Elijah Skarlus Doelakeh, Lydia Kiwanuka, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 4
Stability analysis and numerical simulations for interactions of tumor-immune system with drug delivery
Manisha Yadav, Paramjeet Singh
Chaos Solitons & Fractals (2025) Vol. 192, pp. 115971-115971
Closed Access
Manisha Yadav, Paramjeet Singh
Chaos Solitons & Fractals (2025) Vol. 192, pp. 115971-115971
Closed Access
Advancing brain immunotherapy through functional nanomaterials
Bhanu Nirosha Yalamandala, Thi My Hue Huynh, Hui-Wen Lien, et al.
Drug Delivery and Translational Research (2025)
Open Access
Bhanu Nirosha Yalamandala, Thi My Hue Huynh, Hui-Wen Lien, et al.
Drug Delivery and Translational Research (2025)
Open Access
Therapeutic role of immune cells against colon cancer
Manoj Kumar Gupta, Gayatri Gouda, Ramakrishna Vadde
Elsevier eBooks (2025), pp. 127-146
Closed Access
Manoj Kumar Gupta, Gayatri Gouda, Ramakrishna Vadde
Elsevier eBooks (2025), pp. 127-146
Closed Access
Disabilities in Cancer Patients and Rehabilitation Approaches
Abhishek Krishna, Debasmita Mohanty, M. S. Athiyamaan, et al.
(2025), pp. 1-10
Closed Access
Abhishek Krishna, Debasmita Mohanty, M. S. Athiyamaan, et al.
(2025), pp. 1-10
Closed Access
Immunohistochemical Evaluation of the Tumor Immune Microenvironment in Pancreatic Ductal Adenocarcinoma
Gelu Mihai Brează, Raluca Maria Cloşca, Alexandru Cristian Cindrea, et al.
Diagnostics (2025) Vol. 15, Iss. 5, pp. 646-646
Open Access
Gelu Mihai Brează, Raluca Maria Cloşca, Alexandru Cristian Cindrea, et al.
Diagnostics (2025) Vol. 15, Iss. 5, pp. 646-646
Open Access
Immunity‐Modulating Metal‐Based Nanomaterials for Cancer Immunotherapy
Xing Sun, Xican Xu, Fengying Li, et al.
Advanced Functional Materials (2025)
Closed Access
Xing Sun, Xican Xu, Fengying Li, et al.
Advanced Functional Materials (2025)
Closed Access
